The core of data analysis tools lies in transforming complex data into understandable information. Its main characteristics ...

Dianthus Therapeutics announces positive Phase II results for Claseprubart in myasthenia gravis, highlighting best-in-class potential.

Industry watchers who cheered on Summit Therapeutics’ claim that the first global phase 3 trial of its Akeso-partnered ...

New complementary technologies will also be featured, including SpeedAkin ™ Anatomic Compression Implant used in Akin osteotomy procedures, as well biologics commonly used in foot and ankle fusion ...

ESCCA As a leading forum for scientific exchange in flow cytometry, ESCCA focuses on clinical applications in hematology, immunology, cancer, and cell biology. ESCCA 2025 will be held in Montpellier, ...

An announcement from The Arena Group ( ($AREN) ) is now available. On September 11, 2025, The Arena Group Holdings, Inc. released an updated ...

Merck (MRK) stock in focus as the company posts late-stage trial data to indicate that its Capvaxive pneumonia vaccine is ...

CuFe Limited ( ($AU:CUF) ) has provided an announcement. CuFe Limited has updated its Corporate Presentation to meet ASX Listing Rules ...

EB613 Demonstrates Significant Effects on Both Trabecular and Cortical Bone Compartments After Just 6 Months of Treatment in Phase 2 Study; Cortical Improvements Comparable to Injectable Teriparatide ...

AI startup Metal raises $5 million to build the first operating system for private equity, automating investment research and ...